August 14, 2006

TAMPA, Fla. –H. Lee Moffitt Cancer Center & Research Institute will host a “Business of Biotech” conference Sept. 7 from 8 a.m. to 12 p.m. in the Vincent A. Stabile Research building. The event is free, but reservations are required. Call 888-MOFFITT or go online to and click on the "Business of Biotech" logo for more information and to register. Reservations must be made by Sept. 5.

The conference includes a biotech showcase, behind-the-scenes tour of Moffitt’s research laboratories and two breakout sessions “Ten Secrets of Biotech Science” featuring leading entrepreneurs and scientists and “Personalized Medicine – How Moffitt Scientists Are Making It A Reality” featuring W. Jack Pledger, Ph.D. and Dr. Timothy Yeatman.

The keynote speaker is Steven Gillis, Ph.D. Gillis is a venture partner at ARCH Venture Partners, which invests in the development of seed and early stage technology companies. He was a founder and director of Corixa Corporation and served as the company’s chief executive officer. Gillis is credited as being a pioneer in the field of cytokines and cytokine receptors.

The conference is open to life science companies, scientists, venture capitalists, bankers, attorneys and those interested in learning more about the future of biotech. Moffitt is partnering with Enterprise Florida, Greater Tampa Chamber of Commerce, Pinellas Economic Development, Tampa Bay Partnership and the University of South Florida’s Research Foundation.

-- more --

In 2001, H. Lee Moffitt Cancer Center & Research Institute earned NCI Comprehensive Cancer Center status in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading

cancer centers, and is listed in the U.S. News & World Report as one of the top cancer hospitals in America. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.